S
6600
vs
NOVO B

Over the past 12 months, SciClone Pharmaceuticals (Holdings) Ltd has underperformed NOVO B, delivering a return of 0% compared to the NOVO B's 62% drop.
Smart Verdict
AI-Powered
Let AI Decide.


Valuation Comparison

Growth Comparison
Growth Over Time
6600, NOVO B
All metrics are calculated based on data from the last 10 years.
Profitability Comparison
Gross Margin
Operating Margin
Net Margin
FCF Margin
ROE
ROA
ROIC
ROCE
Solvency Comparison

